Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDIROM Healthcare Technologies Total Payout Ratio Chart
MRM vs EJH, DROR, EVTK: Total Payout Ratio Comparison
For the Personal Services subindustry, MEDIROM Healthcare Technologies's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MEDIROM Healthcare Technologies Total Payout Ratio vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, MEDIROM Healthcare Technologies's Total Payout Ratio distribution charts can be found below:
* The bar in red indicates where MEDIROM Healthcare Technologies's Total Payout Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDIROM Healthcare Technologies (MRM) has a Total Payout Ratio of 67.26 as of Aug. 04, 2026. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on MEDIROM Healthcare Technologies and its competitors.
Is MEDIROM Healthcare Technologies' Total Payout Ratio too high?
MEDIROM Healthcare Technologies' current Total Payout Ratio is 67.26. Overall, MEDIROM Healthcare Technologies has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MEDIROM Healthcare Technologies' Total Payout Ratio compare to EJH and DROR?
MEDIROM Healthcare Technologies' Total Payout Ratio of 67.26 can be compared against companies in the Personal Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Ratio for a Personal Services company?
A good Total Payout Ratio depends on the Personal Services industry context. However, Total Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Ratio mean?
A high Total Payout Ratio can signal that a stock is expensive relative to its fundamentals. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on MEDIROM Healthcare Technologies and its competitors. MEDIROM Healthcare Technologies's current Total Payout Ratio is 67.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDIROM Healthcare Technologies stock overvalued right now?
Based on GuruFocus' analysis, MEDIROM Healthcare Technologies (MRM) is currently considered Possible Value Trap. The stock's GF Value™ is $4.07, compared to a current price of $0.89 — trading 78.1% below its estimated fair value. The current Total Payout Ratio is 67.26. MEDIROM Healthcare Technologies' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Ratio calculated?
Total Payout Ratio is calculated from a company's financial statements. For MEDIROM Healthcare Technologies (MRM), the current Total Payout Ratio is 67.26 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MEDIROM Healthcare Technologies (MRM) Overvalued in 2026?
Based on GuruFocus' analysis, MEDIROM Healthcare Technologies stock appears to be undervalued.
The current stock price of $0.89 is trading 78.1% below its estimated GF Value™ of $4.07.
GuruFocus considers MEDIROM Healthcare Technologies to be Possible Value Trap.
Key valuation signals for MRM:
Total Payout Ratio: 67.26
GF Value™: $4.07 vs. price of $0.89 (78.1% below fair value)
No single metric tells the full story. See the MRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
53GF Score
Get the complete analysis for MRM
Total Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MRM has been successfully added to your 
